dc.contributor.author | Cascio, Maria Grazia | |
dc.contributor.author | Zamberletti, Erica | |
dc.contributor.author | Marini, Pietro | |
dc.contributor.author | Parolaro, Daniela | |
dc.contributor.author | Pertwee, Roger G. | |
dc.date.accessioned | 2016-03-01T00:01:09Z | |
dc.date.available | 2016-03-01T00:01:09Z | |
dc.date.issued | 2015-03 | |
dc.identifier | 47821289 | |
dc.identifier | a60aefb3-f35d-4511-8402-6b5195dcf77b | |
dc.identifier | 84922798573 | |
dc.identifier.citation | Cascio , M G , Zamberletti , E , Marini , P , Parolaro , D & Pertwee , R G 2015 , ' The phytocannabinoid, Δ(9) -tetrahydrocannabivarin, can act through 5-HT1 A receptors to produce antipsychotic effects ' , British Journal of Pharmacology , vol. 172 , no. 5 , pp. 1305-1318 . https://doi.org/10.1111/bph.13000 | en |
dc.identifier.issn | 0007-1188 | |
dc.identifier.uri | http://hdl.handle.net/2164/5584 | |
dc.description | Funded by: •GW Pharmaceuticals Acknowledgements: The authors wish to thank Mrs Lesley Stevenson for technical support and Dr John Raymond, Dr Keith Parker and Dr Ethan Russo for providing human 5-HT1A CHO cells. This research was supported by a grant from GW Pharmaceuticals to M. G. C. and R. G. P. | en |
dc.format.extent | 14 | |
dc.format.extent | 1556170 | |
dc.language.iso | eng | |
dc.relation.ispartof | British Journal of Pharmacology | en |
dc.subject | RM Therapeutics. Pharmacology | en |
dc.subject.lcc | RM | en |
dc.title | The phytocannabinoid, Δ(9) -tetrahydrocannabivarin, can act through 5-HT1 A receptors to produce antipsychotic effects | en |
dc.type | Journal article | en |
dc.contributor.institution | University of Aberdeen.Medical Sciences | en |
dc.contributor.institution | University of Aberdeen.Medical Education | en |
dc.contributor.institution | University of Aberdeen.Medical Sciences - Cardiovascular Group | en |
dc.description.status | Peer reviewed | en |
dc.identifier.doi | 10.1111/bph.13000 | |
dc.date.embargoedUntil | 2016-03-01 | |